Philippines Lawmaker Says WTO Rules Slipped Into Cheap Medicines Bill
This article was originally published in PharmAsia News
A representative in the Philippines House says a drug industry consultant revealed that provisions sneaked into a "cheap-medicines" bill approved by the House would moot its effects. The measure is intended to make drugs more competitive and thus bring about lower prices. But one of the bill's supporters said he was told by the consultant that provisions had been slipped into the bill to make provisions of a World Trade Organization agreement paramount to local law and thus block Indian generics. The provisions are in the Trade Related Aspects of Intellectual Property Rights agreement that allows multinationals to patent their drugs in India. (Click here for more
You may also be interested in...
Pink Sheet reporters and editors look at the UK MHRA’s surprising approval of the Pfizer/BioNTech coronavirus vaccine, as well as the US reaction, and discuss President-elect Joe Biden’s potential US FDA commissioner nominees.
Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.
The US FDA tells manufacturers in two recent warning letters to get to the root cause of contamination problems and take a more proactive approach to cleaning and equipment maintenance.